<?xml version="1.0" encoding="UTF-8"?><xmi:XMI xmlns:pos="http:///de/tudarmstadt/ukp/dkpro/core/api/lexmorph/type/pos.ecore" xmlns:tcas="http:///uima/tcas.ecore" xmlns:chebi="http:///uk/ac/nactem/uima/chebi.ecore" xmlns:xmi="http://www.omg.org/XMI" xmlns:cas="http:///uima/cas.ecore" xmlns:type="http:///de/tudarmstadt/ukp/dkpro/core/api/metadata/type.ecore" xmlns:tweet="http:///de/tudarmstadt/ukp/dkpro/core/api/lexmorph/type/pos/tweet.ecore" xmlns:morph="http:///de/tudarmstadt/ukp/dkpro/core/api/lexmorph/type/morph.ecore" xmlns:type2="http:///de/tudarmstadt/ukp/dkpro/core/api/segmentation/type.ecore" xmi:version="2.0"><cas:NULL xmi:id="0"/><type:DocumentMetaData xmi:id="1" sofa="2182" begin="0" end="41248" language="x-unspecified" documentTitle="fphar-09-00130.pdf" documentId="fphar-09-00130.pdf" documentUri="file:/opt/omtd-component-executor/scripts/working/tmp/fphar-09-00130.pdf" collectionId="file:/opt/omtd-component-executor/scripts/working/tmp/" documentBaseUri="file:/opt/omtd-component-executor/scripts/working/tmp/" isLastSegment="false"/><chebi:Protein xmi:id="12" sofa="2182" begin="2181" end="2183"/><chebi:Protein xmi:id="17" sofa="2182" begin="3977" end="4000"/><chebi:Protein xmi:id="22" sofa="2182" begin="4585" end="4591"/><chebi:Protein xmi:id="27" sofa="2182" begin="14893" end="14895"/><chebi:Protein xmi:id="32" sofa="2182" begin="15054" end="15066"/><chebi:Protein xmi:id="37" sofa="2182" begin="16885" end="16897"/><chebi:Protein xmi:id="42" sofa="2182" begin="17844" end="17860"/><chebi:Protein xmi:id="47" sofa="2182" begin="28208" end="28223"/><chebi:Protein xmi:id="52" sofa="2182" begin="33259" end="33266"/><chebi:Protein xmi:id="57" sofa="2182" begin="33751" end="33753"/><chebi:Protein xmi:id="62" sofa="2182" begin="36254" end="36271"/><chebi:Protein xmi:id="67" sofa="2182" begin="37857" end="37885"/><chebi:Protein xmi:id="72" sofa="2182" begin="38675" end="38690"/><chebi:Protein xmi:id="77" sofa="2182" begin="38960" end="38975"/><chebi:Metabolite xmi:id="82" sofa="2182" begin="1872" end="1883"/><chebi:Metabolite xmi:id="87" sofa="2182" begin="1995" end="2006"/><chebi:Metabolite xmi:id="92" sofa="2182" begin="2044" end="2055"/><chebi:Metabolite xmi:id="97" sofa="2182" begin="2164" end="2175"/><chebi:Metabolite xmi:id="102" sofa="2182" begin="2357" end="2368"/><chebi:Metabolite xmi:id="107" sofa="2182" begin="2370" end="2384"/><chebi:Metabolite xmi:id="112" sofa="2182" begin="2407" end="2409"/><chebi:Metabolite xmi:id="117" sofa="2182" begin="4331" end="4362"/><chebi:Metabolite xmi:id="122" sofa="2182" begin="4514" end="4534"/><chebi:Metabolite xmi:id="127" sofa="2182" begin="6232" end="6242"/><chebi:Metabolite xmi:id="132" sofa="2182" begin="6244" end="6254"/><chebi:Metabolite xmi:id="137" sofa="2182" begin="6599" end="6610"/><chebi:Metabolite xmi:id="142" sofa="2182" begin="6813" end="6824"/><chebi:Metabolite xmi:id="147" sofa="2182" begin="6948" end="6959"/><chebi:Metabolite xmi:id="152" sofa="2182" begin="7001" end="7011"/><chebi:Metabolite xmi:id="157" sofa="2182" begin="7209" end="7223"/><chebi:Metabolite xmi:id="162" sofa="2182" begin="7250" end="7261"/><chebi:Metabolite xmi:id="167" sofa="2182" begin="7688" end="7757"/><chebi:Metabolite xmi:id="172" sofa="2182" begin="12454" end="12465"/><chebi:Metabolite xmi:id="177" sofa="2182" begin="12704" end="12715"/><chebi:Metabolite xmi:id="182" sofa="2182" begin="13773" end="13784"/><chebi:Metabolite xmi:id="187" sofa="2182" begin="14259" end="14270"/><chebi:Metabolite xmi:id="192" sofa="2182" begin="14352" end="14366"/><chebi:Metabolite xmi:id="197" sofa="2182" begin="14389" end="14400"/><chebi:Metabolite xmi:id="202" sofa="2182" begin="14624" end="14635"/><chebi:Metabolite xmi:id="207" sofa="2182" begin="14768" end="14779"/><chebi:Metabolite xmi:id="212" sofa="2182" begin="14876" end="14887"/><chebi:Metabolite xmi:id="217" sofa="2182" begin="15035" end="15049"/><chebi:Metabolite xmi:id="222" sofa="2182" begin="15054" end="15059"/><chebi:Metabolite xmi:id="227" sofa="2182" begin="15064" end="15066"/><chebi:Metabolite xmi:id="232" sofa="2182" begin="15577" end="15579"/><chebi:Metabolite xmi:id="237" sofa="2182" begin="15995" end="15997"/><chebi:Metabolite xmi:id="242" sofa="2182" begin="16252" end="16263"/><chebi:Metabolite xmi:id="247" sofa="2182" begin="16765" end="16767"/><chebi:Metabolite xmi:id="252" sofa="2182" begin="16866" end="16880"/><chebi:Metabolite xmi:id="257" sofa="2182" begin="16951" end="16962"/><chebi:Metabolite xmi:id="262" sofa="2182" begin="17201" end="17203"/><chebi:Metabolite xmi:id="267" sofa="2182" begin="17608" end="17623"/><chebi:Metabolite xmi:id="272" sofa="2182" begin="18503" end="18535"/><chebi:Metabolite xmi:id="277" sofa="2182" begin="18564" end="18585"/><chebi:Metabolite xmi:id="282" sofa="2182" begin="18611" end="18613"/><chebi:Metabolite xmi:id="287" sofa="2182" begin="18617" end="18633"/><chebi:Metabolite xmi:id="292" sofa="2182" begin="18819" end="18829"/><chebi:Metabolite xmi:id="297" sofa="2182" begin="19206" end="19217"/><chebi:Metabolite xmi:id="302" sofa="2182" begin="21777" end="21787"/><chebi:Metabolite xmi:id="307" sofa="2182" begin="22434" end="22436"/><chebi:Metabolite xmi:id="312" sofa="2182" begin="22455" end="22471"/><chebi:Metabolite xmi:id="317" sofa="2182" begin="22884" end="22886"/><chebi:Metabolite xmi:id="322" sofa="2182" begin="22937" end="22939"/><chebi:Metabolite xmi:id="327" sofa="2182" begin="23518" end="23549"/><chebi:Metabolite xmi:id="332" sofa="2182" begin="23578" end="23599"/><chebi:Metabolite xmi:id="337" sofa="2182" begin="23625" end="23627"/><chebi:Metabolite xmi:id="342" sofa="2182" begin="23631" end="23641"/><chebi:Metabolite xmi:id="347" sofa="2182" begin="24306" end="24316"/><chebi:Metabolite xmi:id="352" sofa="2182" begin="25144" end="25154"/><chebi:Metabolite xmi:id="357" sofa="2182" begin="25684" end="25705"/><chebi:Metabolite xmi:id="362" sofa="2182" begin="25818" end="25828"/><chebi:Metabolite xmi:id="367" sofa="2182" begin="26552" end="26562"/><chebi:Metabolite xmi:id="372" sofa="2182" begin="27125" end="27135"/><chebi:Metabolite xmi:id="377" sofa="2182" begin="28188" end="28199"/><chebi:Metabolite xmi:id="382" sofa="2182" begin="28277" end="28288"/><chebi:Metabolite xmi:id="387" sofa="2182" begin="29209" end="29227"/><chebi:Metabolite xmi:id="392" sofa="2182" begin="29414" end="29424"/><chebi:Metabolite xmi:id="397" sofa="2182" begin="29640" end="29650"/><chebi:Metabolite xmi:id="402" sofa="2182" begin="29682" end="29692"/><chebi:Metabolite xmi:id="407" sofa="2182" begin="30691" end="30693"/><chebi:Metabolite xmi:id="412" sofa="2182" begin="30751" end="30773"/><chebi:Metabolite xmi:id="417" sofa="2182" begin="31120" end="31142"/><chebi:Metabolite xmi:id="422" sofa="2182" begin="31825" end="31845"/><chebi:Metabolite xmi:id="427" sofa="2182" begin="32027" end="32047"/><chebi:Metabolite xmi:id="432" sofa="2182" begin="32156" end="32176"/><chebi:Metabolite xmi:id="437" sofa="2182" begin="32634" end="32658"/><chebi:Metabolite xmi:id="442" sofa="2182" begin="32712" end="32723"/><chebi:Metabolite xmi:id="447" sofa="2182" begin="32878" end="32880"/><chebi:Metabolite xmi:id="452" sofa="2182" begin="33167" end="33177"/><chebi:Metabolite xmi:id="457" sofa="2182" begin="33314" end="33325"/><chebi:Metabolite xmi:id="462" sofa="2182" begin="33567" end="33578"/><chebi:Metabolite xmi:id="467" sofa="2182" begin="33660" end="33674"/><chebi:Metabolite xmi:id="472" sofa="2182" begin="33701" end="33712"/><chebi:Metabolite xmi:id="477" sofa="2182" begin="33733" end="33744"/><chebi:Metabolite xmi:id="482" sofa="2182" begin="34229" end="34240"/><chebi:Metabolite xmi:id="487" sofa="2182" begin="36477" end="36487"/><chebi:Metabolite xmi:id="492" sofa="2182" begin="36950" end="36960"/><chebi:Metabolite xmi:id="497" sofa="2182" begin="37537" end="37551"/><chebi:Metabolite xmi:id="502" sofa="2182" begin="38126" end="38140"/><chebi:Metabolite xmi:id="507" sofa="2182" begin="38169" end="38198"/><chebi:Metabolite xmi:id="512" sofa="2182" begin="38650" end="38661"/><chebi:Chemical xmi:id="517" sofa="2182" begin="808" end="818"/><chebi:Chemical xmi:id="522" sofa="2182" begin="1013" end="1023"/><chebi:Chemical xmi:id="527" sofa="2182" begin="1445" end="1455"/><chebi:Chemical xmi:id="532" sofa="2182" begin="1462" end="1488"/><chebi:Chemical xmi:id="537" sofa="2182" begin="1704" end="1714"/><chebi:Chemical xmi:id="542" sofa="2182" begin="1872" end="1883"/><chebi:Chemical xmi:id="547" sofa="2182" begin="1957" end="1968"/><chebi:Chemical xmi:id="552" sofa="2182" begin="1995" end="2006"/><chebi:Chemical xmi:id="557" sofa="2182" begin="2044" end="2055"/><chebi:Chemical xmi:id="562" sofa="2182" begin="2193" end="2195"/><chebi:Chemical xmi:id="567" sofa="2182" begin="2357" end="2384"/><chebi:Chemical xmi:id="572" sofa="2182" begin="2542" end="2545"/><chebi:Chemical xmi:id="577" sofa="2182" begin="2596" end="2606"/><chebi:Chemical xmi:id="582" sofa="2182" begin="2643" end="2653"/><chebi:Chemical xmi:id="587" sofa="2182" begin="2666" end="2676"/><chebi:Chemical xmi:id="592" sofa="2182" begin="2731" end="2741"/><chebi:Chemical xmi:id="597" sofa="2182" begin="2801" end="2811"/><chebi:Chemical xmi:id="602" sofa="2182" begin="2868" end="2878"/><chebi:Chemical xmi:id="607" sofa="2182" begin="3181" end="3191"/><chebi:Chemical xmi:id="612" sofa="2182" begin="3207" end="3233"/><chebi:Chemical xmi:id="617" sofa="2182" begin="3346" end="3356"/><chebi:Chemical xmi:id="622" sofa="2182" begin="3620" end="3630"/><chebi:Chemical xmi:id="627" sofa="2182" begin="3744" end="3754"/><chebi:Chemical xmi:id="632" sofa="2182" begin="4071" end="4081"/><chebi:Chemical xmi:id="637" sofa="2182" begin="4237" end="4247"/><chebi:Chemical xmi:id="642" sofa="2182" begin="4282" end="4295"/><chebi:Chemical xmi:id="647" sofa="2182" begin="4331" end="4362"/><chebi:Chemical xmi:id="652" sofa="2182" begin="4397" end="4407"/><chebi:Chemical xmi:id="657" sofa="2182" begin="4459" end="4469"/><chebi:Chemical xmi:id="662" sofa="2182" begin="4514" end="4535"/><chebi:Chemical xmi:id="667" sofa="2182" begin="4540" end="4550"/><chebi:Chemical xmi:id="672" sofa="2182" begin="4685" end="4695"/><chebi:Chemical xmi:id="677" sofa="2182" begin="4752" end="4762"/><chebi:Chemical xmi:id="682" sofa="2182" begin="4829" end="4839"/><chebi:Chemical xmi:id="687" sofa="2182" begin="4853" end="4863"/><chebi:Chemical xmi:id="692" sofa="2182" begin="4921" end="4931"/><chebi:Chemical xmi:id="697" sofa="2182" begin="4986" end="4990"/><chebi:Chemical xmi:id="702" sofa="2182" begin="5219" end="5223"/><chebi:Chemical xmi:id="707" sofa="2182" begin="5531" end="5582"/><chebi:Chemical xmi:id="712" sofa="2182" begin="5584" end="5589"/><chebi:Chemical xmi:id="717" sofa="2182" begin="5594" end="5632"/><chebi:Chemical xmi:id="722" sofa="2182" begin="5788" end="5792"/><chebi:Chemical xmi:id="727" sofa="2182" begin="6124" end="6128"/><chebi:Chemical xmi:id="732" sofa="2182" begin="6232" end="6242"/><chebi:Chemical xmi:id="737" sofa="2182" begin="6350" end="6360"/><chebi:Chemical xmi:id="742" sofa="2182" begin="6599" end="6610"/><chebi:Chemical xmi:id="747" sofa="2182" begin="6813" end="6824"/><chebi:Chemical xmi:id="752" sofa="2182" begin="6948" end="6959"/><chebi:Chemical xmi:id="757" sofa="2182" begin="7001" end="7011"/><chebi:Chemical xmi:id="762" sofa="2182" begin="7036" end="7046"/><chebi:Chemical xmi:id="767" sofa="2182" begin="7177" end="7187"/><chebi:Chemical xmi:id="772" sofa="2182" begin="7250" end="7261"/><chebi:Chemical xmi:id="777" sofa="2182" begin="7323" end="7326"/><chebi:Chemical xmi:id="782" sofa="2182" begin="7403" end="7413"/><chebi:Chemical xmi:id="787" sofa="2182" begin="7462" end="7472"/><chebi:Chemical xmi:id="792" sofa="2182" begin="7563" end="7583"/><chebi:Chemical xmi:id="797" sofa="2182" begin="7667" end="7686"/><chebi:Chemical xmi:id="802" sofa="2182" begin="7688" end="7719"/><chebi:Chemical xmi:id="807" sofa="2182" begin="7725" end="7757"/><chebi:Chemical xmi:id="812" sofa="2182" begin="8200" end="8205"/><chebi:Chemical xmi:id="817" sofa="2182" begin="8210" end="8220"/><chebi:Chemical xmi:id="822" sofa="2182" begin="8297" end="8302"/><chebi:Chemical xmi:id="827" sofa="2182" begin="8514" end="8524"/><chebi:Chemical xmi:id="832" sofa="2182" begin="8651" end="8663"/><chebi:Chemical xmi:id="837" sofa="2182" begin="8745" end="8748"/><chebi:Chemical xmi:id="842" sofa="2182" begin="9039" end="9051"/><chebi:Chemical xmi:id="847" sofa="2182" begin="9175" end="9183"/><chebi:Chemical xmi:id="852" sofa="2182" begin="9262" end="9274"/><chebi:Chemical xmi:id="857" sofa="2182" begin="9473" end="9483"/><chebi:Chemical xmi:id="862" sofa="2182" begin="9655" end="9665"/><chebi:Chemical xmi:id="867" sofa="2182" begin="9760" end="9763"/><chebi:Chemical xmi:id="872" sofa="2182" begin="9800" end="9810"/><chebi:Chemical xmi:id="877" sofa="2182" begin="9827" end="9839"/><chebi:Chemical xmi:id="882" sofa="2182" begin="9868" end="9880"/><chebi:Chemical xmi:id="887" sofa="2182" begin="9974" end="9977"/><chebi:Chemical xmi:id="892" sofa="2182" begin="10011" end="10021"/><chebi:Chemical xmi:id="897" sofa="2182" begin="10090" end="10109"/><chebi:Chemical xmi:id="902" sofa="2182" begin="10308" end="10313"/><chebi:Chemical xmi:id="907" sofa="2182" begin="10325" end="10330"/><chebi:Chemical xmi:id="912" sofa="2182" begin="10451" end="10463"/><chebi:Chemical xmi:id="917" sofa="2182" begin="10587" end="10595"/><chebi:Chemical xmi:id="922" sofa="2182" begin="10674" end="10686"/><chebi:Chemical xmi:id="927" sofa="2182" begin="11198" end="11209"/><chebi:Chemical xmi:id="932" sofa="2182" begin="11213" end="11218"/><chebi:Chemical xmi:id="937" sofa="2182" begin="11232" end="11243"/><chebi:Chemical xmi:id="942" sofa="2182" begin="11247" end="11259"/><chebi:Chemical xmi:id="947" sofa="2182" begin="12107" end="12113"/><chebi:Chemical xmi:id="952" sofa="2182" begin="12454" end="12465"/><chebi:Chemical xmi:id="957" sofa="2182" begin="12628" end="12638"/><chebi:Chemical xmi:id="962" sofa="2182" begin="12704" end="12715"/><chebi:Chemical xmi:id="967" sofa="2182" begin="12752" end="12762"/><chebi:Chemical xmi:id="972" sofa="2182" begin="12936" end="12946"/><chebi:Chemical xmi:id="977" sofa="2182" begin="13111" end="13121"/><chebi:Chemical xmi:id="982" sofa="2182" begin="13267" end="13277"/><chebi:Chemical xmi:id="987" sofa="2182" begin="13413" end="13432"/><chebi:Chemical xmi:id="992" sofa="2182" begin="13437" end="13446"/><chebi:Chemical xmi:id="997" sofa="2182" begin="13466" end="13480"/><chebi:Chemical xmi:id="1002" sofa="2182" begin="13773" end="13833"/><chebi:Chemical xmi:id="1007" sofa="2182" begin="14183" end="14194"/><chebi:Chemical xmi:id="1012" sofa="2182" begin="14259" end="14270"/><chebi:Chemical xmi:id="1017" sofa="2182" begin="14389" end="14400"/><chebi:Chemical xmi:id="1022" sofa="2182" begin="14473" end="14484"/><chebi:Chemical xmi:id="1027" sofa="2182" begin="14624" end="14635"/><chebi:Chemical xmi:id="1032" sofa="2182" begin="14768" end="14779"/><chebi:Chemical xmi:id="1037" sofa="2182" begin="14876" end="14887"/><chebi:Chemical xmi:id="1042" sofa="2182" begin="14905" end="14907"/><chebi:Chemical xmi:id="1047" sofa="2182" begin="15356" end="15366"/><chebi:Chemical xmi:id="1052" sofa="2182" begin="15395" end="15405"/><chebi:Chemical xmi:id="1057" sofa="2182" begin="15542" end="15552"/><chebi:Chemical xmi:id="1062" sofa="2182" begin="15577" end="15622"/><chebi:Chemical xmi:id="1067" sofa="2182" begin="15757" end="15766"/><chebi:Chemical xmi:id="1072" sofa="2182" begin="15858" end="15877"/><chebi:Chemical xmi:id="1077" sofa="2182" begin="15995" end="15997"/><chebi:Chemical xmi:id="1082" sofa="2182" begin="16198" end="16208"/><chebi:Chemical xmi:id="1087" sofa="2182" begin="16252" end="16309"/><chebi:Chemical xmi:id="1092" sofa="2182" begin="16339" end="16359"/><chebi:Chemical xmi:id="1097" sofa="2182" begin="16506" end="16525"/><chebi:Chemical xmi:id="1102" sofa="2182" begin="16643" end="16652"/><chebi:Chemical xmi:id="1107" sofa="2182" begin="16765" end="16767"/><chebi:Chemical xmi:id="1112" sofa="2182" begin="16795" end="16814"/><chebi:Chemical xmi:id="1117" sofa="2182" begin="16844" end="16863"/><chebi:Chemical xmi:id="1122" sofa="2182" begin="16951" end="16962"/><chebi:Chemical xmi:id="1127" sofa="2182" begin="17078" end="17088"/><chebi:Chemical xmi:id="1132" sofa="2182" begin="17155" end="17158"/><chebi:Chemical xmi:id="1137" sofa="2182" begin="17174" end="17184"/><chebi:Chemical xmi:id="1142" sofa="2182" begin="17201" end="17203"/><chebi:Chemical xmi:id="1147" sofa="2182" begin="17321" end="17330"/><chebi:Chemical xmi:id="1152" sofa="2182" begin="17358" end="17373"/><chebi:Chemical xmi:id="1157" sofa="2182" begin="17534" end="17537"/><chebi:Chemical xmi:id="1162" sofa="2182" begin="17562" end="17571"/><chebi:Chemical xmi:id="1167" sofa="2182" begin="17608" end="17623"/><chebi:Chemical xmi:id="1172" sofa="2182" begin="17650" end="17663"/><chebi:Chemical xmi:id="1177" sofa="2182" begin="17715" end="17718"/><chebi:Chemical xmi:id="1182" sofa="2182" begin="17821" end="17841"/><chebi:Chemical xmi:id="1187" sofa="2182" begin="18059" end="18070"/><chebi:Chemical xmi:id="1192" sofa="2182" begin="18086" end="18096"/><chebi:Chemical xmi:id="1197" sofa="2182" begin="18227" end="18237"/><chebi:Chemical xmi:id="1202" sofa="2182" begin="18366" end="18375"/><chebi:Chemical xmi:id="1207" sofa="2182" begin="18503" end="18535"/><chebi:Chemical xmi:id="1212" sofa="2182" begin="18564" end="18609"/><chebi:Chemical xmi:id="1217" sofa="2182" begin="18611" end="18613"/><chebi:Chemical xmi:id="1222" sofa="2182" begin="18819" end="18829"/><chebi:Chemical xmi:id="1227" sofa="2182" begin="18833" end="18843"/><chebi:Chemical xmi:id="1232" sofa="2182" begin="19089" end="19099"/><chebi:Chemical xmi:id="1237" sofa="2182" begin="19140" end="19165"/><chebi:Chemical xmi:id="1242" sofa="2182" begin="19652" end="19655"/><chebi:Chemical xmi:id="1247" sofa="2182" begin="19827" end="19830"/><chebi:Chemical xmi:id="1252" sofa="2182" begin="21604" end="21614"/><chebi:Chemical xmi:id="1257" sofa="2182" begin="21777" end="21787"/><chebi:Chemical xmi:id="1262" sofa="2182" begin="21987" end="22006"/><chebi:Chemical xmi:id="1267" sofa="2182" begin="22039" end="22049"/><chebi:Chemical xmi:id="1272" sofa="2182" begin="22204" end="22213"/><chebi:Chemical xmi:id="1277" sofa="2182" begin="22280" end="22283"/><chebi:Chemical xmi:id="1282" sofa="2182" begin="22391" end="22401"/><chebi:Chemical xmi:id="1287" sofa="2182" begin="22830" end="22840"/><chebi:Chemical xmi:id="1292" sofa="2182" begin="22868" end="22870"/><chebi:Chemical xmi:id="1297" sofa="2182" begin="22884" end="22886"/><chebi:Chemical xmi:id="1302" sofa="2182" begin="22937" end="22939"/><chebi:Chemical xmi:id="1307" sofa="2182" begin="22997" end="23008"/><chebi:Chemical xmi:id="1312" sofa="2182" begin="23024" end="23034"/><chebi:Chemical xmi:id="1317" sofa="2182" begin="23177" end="23187"/><chebi:Chemical xmi:id="1322" sofa="2182" begin="23326" end="23345"/><chebi:Chemical xmi:id="1327" sofa="2182" begin="23362" end="23371"/><chebi:Chemical xmi:id="1332" sofa="2182" begin="23518" end="23549"/><chebi:Chemical xmi:id="1337" sofa="2182" begin="23578" end="23599"/><chebi:Chemical xmi:id="1342" sofa="2182" begin="23606" end="23623"/><chebi:Chemical xmi:id="1347" sofa="2182" begin="23625" end="23627"/><chebi:Chemical xmi:id="1352" sofa="2182" begin="23857" end="23867"/><chebi:Chemical xmi:id="1357" sofa="2182" begin="23957" end="23976"/><chebi:Chemical xmi:id="1362" sofa="2182" begin="24001" end="24010"/><chebi:Chemical xmi:id="1367" sofa="2182" begin="24125" end="24144"/><chebi:Chemical xmi:id="1372" sofa="2182" begin="24187" end="24197"/><chebi:Chemical xmi:id="1377" sofa="2182" begin="24545" end="24555"/><chebi:Chemical xmi:id="1382" sofa="2182" begin="24739" end="24749"/><chebi:Chemical xmi:id="1387" sofa="2182" begin="24929" end="24938"/><chebi:Chemical xmi:id="1392" sofa="2182" begin="25029" end="25048"/><chebi:Chemical xmi:id="1397" sofa="2182" begin="25131" end="25141"/><chebi:Chemical xmi:id="1402" sofa="2182" begin="25359" end="25370"/><chebi:Chemical xmi:id="1407" sofa="2182" begin="25459" end="25469"/><chebi:Chemical xmi:id="1412" sofa="2182" begin="25634" end="25643"/><chebi:Chemical xmi:id="1417" sofa="2182" begin="25684" end="25705"/><chebi:Chemical xmi:id="1422" sofa="2182" begin="25759" end="25771"/><chebi:Chemical xmi:id="1427" sofa="2182" begin="25786" end="25796"/><chebi:Chemical xmi:id="1432" sofa="2182" begin="26151" end="26170"/><chebi:Chemical xmi:id="1437" sofa="2182" begin="26262" end="26271"/><chebi:Chemical xmi:id="1442" sofa="2182" begin="26343" end="26346"/><chebi:Chemical xmi:id="1447" sofa="2182" begin="26454" end="26464"/><chebi:Chemical xmi:id="1452" sofa="2182" begin="26908" end="26925"/><chebi:Chemical xmi:id="1457" sofa="2182" begin="27041" end="27050"/><chebi:Chemical xmi:id="1462" sofa="2182" begin="27450" end="27469"/><chebi:Chemical xmi:id="1467" sofa="2182" begin="27566" end="27583"/><chebi:Chemical xmi:id="1472" sofa="2182" begin="27655" end="27661"/><chebi:Chemical xmi:id="1477" sofa="2182" begin="27758" end="27768"/><chebi:Chemical xmi:id="1482" sofa="2182" begin="28039" end="28049"/><chebi:Chemical xmi:id="1487" sofa="2182" begin="28277" end="28288"/><chebi:Chemical xmi:id="1492" sofa="2182" begin="28445" end="28458"/><chebi:Chemical xmi:id="1497" sofa="2182" begin="28608" end="28617"/><chebi:Chemical xmi:id="1502" sofa="2182" begin="28645" end="28656"/><chebi:Chemical xmi:id="1507" sofa="2182" begin="28738" end="28751"/><chebi:Chemical xmi:id="1512" sofa="2182" begin="28807" end="28824"/><chebi:Chemical xmi:id="1517" sofa="2182" begin="28890" end="28893"/><chebi:Chemical xmi:id="1522" sofa="2182" begin="29100" end="29110"/><chebi:Chemical xmi:id="1527" sofa="2182" begin="29154" end="29164"/><chebi:Chemical xmi:id="1532" sofa="2182" begin="29386" end="29389"/><chebi:Chemical xmi:id="1537" sofa="2182" begin="29414" end="29424"/><chebi:Chemical xmi:id="1542" sofa="2182" begin="29428" end="29438"/><chebi:Chemical xmi:id="1547" sofa="2182" begin="29612" end="29615"/><chebi:Chemical xmi:id="1552" sofa="2182" begin="29640" end="29650"/><chebi:Chemical xmi:id="1557" sofa="2182" begin="29894" end="29897"/><chebi:Chemical xmi:id="1562" sofa="2182" begin="30101" end="30118"/><chebi:Chemical xmi:id="1567" sofa="2182" begin="30199" end="30202"/><chebi:Chemical xmi:id="1572" sofa="2182" begin="30228" end="30238"/><chebi:Chemical xmi:id="1577" sofa="2182" begin="30262" end="30272"/><chebi:Chemical xmi:id="1582" sofa="2182" begin="30489" end="30499"/><chebi:Chemical xmi:id="1587" sofa="2182" begin="30577" end="30583"/><chebi:Chemical xmi:id="1592" sofa="2182" begin="30599" end="30624"/><chebi:Chemical xmi:id="1597" sofa="2182" begin="30675" end="30689"/><chebi:Chemical xmi:id="1602" sofa="2182" begin="30691" end="30693"/><chebi:Chemical xmi:id="1607" sofa="2182" begin="30715" end="30728"/><chebi:Chemical xmi:id="1612" sofa="2182" begin="30751" end="30773"/><chebi:Chemical xmi:id="1617" sofa="2182" begin="30899" end="30901"/><chebi:Chemical xmi:id="1622" sofa="2182" begin="31080" end="31083"/><chebi:Chemical xmi:id="1627" sofa="2182" begin="31120" end="31144"/><chebi:Chemical xmi:id="1632" sofa="2182" begin="31224" end="31267"/><chebi:Chemical xmi:id="1637" sofa="2182" begin="31276" end="31287"/><chebi:Chemical xmi:id="1642" sofa="2182" begin="31342" end="31345"/><chebi:Chemical xmi:id="1647" sofa="2182" begin="31422" end="31432"/><chebi:Chemical xmi:id="1652" sofa="2182" begin="31531" end="31540"/><chebi:Chemical xmi:id="1657" sofa="2182" begin="31770" end="31780"/><chebi:Chemical xmi:id="1662" sofa="2182" begin="31825" end="31845"/><chebi:Chemical xmi:id="1667" sofa="2182" begin="31896" end="31906"/><chebi:Chemical xmi:id="1672" sofa="2182" begin="31961" end="31971"/><chebi:Chemical xmi:id="1677" sofa="2182" begin="32085" end="32100"/><chebi:Chemical xmi:id="1682" sofa="2182" begin="32603" end="32613"/><chebi:Chemical xmi:id="1687" sofa="2182" begin="32634" end="32672"/><chebi:Chemical xmi:id="1692" sofa="2182" begin="32712" end="32723"/><chebi:Chemical xmi:id="1697" sofa="2182" begin="32776" end="32786"/><chebi:Chemical xmi:id="1702" sofa="2182" begin="32848" end="32859"/><chebi:Chemical xmi:id="1707" sofa="2182" begin="32940" end="32950"/><chebi:Chemical xmi:id="1712" sofa="2182" begin="33074" end="33084"/><chebi:Chemical xmi:id="1717" sofa="2182" begin="33167" end="33177"/><chebi:Chemical xmi:id="1722" sofa="2182" begin="33245" end="33255"/><chebi:Chemical xmi:id="1727" sofa="2182" begin="33314" end="33325"/><chebi:Chemical xmi:id="1732" sofa="2182" begin="33479" end="33504"/><chebi:Chemical xmi:id="1737" sofa="2182" begin="33567" end="33578"/><chebi:Chemical xmi:id="1742" sofa="2182" begin="33701" end="33712"/><chebi:Chemical xmi:id="1747" sofa="2182" begin="33763" end="33765"/><chebi:Chemical xmi:id="1752" sofa="2182" begin="33905" end="33915"/><chebi:Chemical xmi:id="1757" sofa="2182" begin="34007" end="34010"/><chebi:Chemical xmi:id="1762" sofa="2182" begin="34136" end="34146"/><chebi:Chemical xmi:id="1767" sofa="2182" begin="34324" end="34326"/><chebi:Chemical xmi:id="1772" sofa="2182" begin="34736" end="34740"/><chebi:Chemical xmi:id="1777" sofa="2182" begin="35067" end="35088"/><chebi:Chemical xmi:id="1782" sofa="2182" begin="35271" end="35288"/><chebi:Chemical xmi:id="1787" sofa="2182" begin="35293" end="35303"/><chebi:Chemical xmi:id="1792" sofa="2182" begin="35307" end="35319"/><chebi:Chemical xmi:id="1797" sofa="2182" begin="35445" end="35455"/><chebi:Chemical xmi:id="1802" sofa="2182" begin="35477" end="35485"/><chebi:Chemical xmi:id="1807" sofa="2182" begin="35701" end="35708"/><chebi:Chemical xmi:id="1812" sofa="2182" begin="35906" end="35913"/><chebi:Chemical xmi:id="1817" sofa="2182" begin="36207" end="36217"/><chebi:Chemical xmi:id="1822" sofa="2182" begin="36458" end="36468"/><chebi:Chemical xmi:id="1827" sofa="2182" begin="36477" end="36487"/><chebi:Chemical xmi:id="1832" sofa="2182" begin="36688" end="36700"/><chebi:Chemical xmi:id="1837" sofa="2182" begin="36887" end="36897"/><chebi:Chemical xmi:id="1842" sofa="2182" begin="36901" end="36912"/><chebi:Chemical xmi:id="1847" sofa="2182" begin="36950" end="36960"/><chebi:Chemical xmi:id="1852" sofa="2182" begin="37005" end="37012"/><chebi:Chemical xmi:id="1857" sofa="2182" begin="37179" end="37189"/><chebi:Chemical xmi:id="1862" sofa="2182" begin="37537" end="37551"/><chebi:Chemical xmi:id="1867" sofa="2182" begin="37815" end="37825"/><chebi:Chemical xmi:id="1872" sofa="2182" begin="37954" end="37970"/><chebi:Chemical xmi:id="1877" sofa="2182" begin="38109" end="38121"/><chebi:Chemical xmi:id="1882" sofa="2182" begin="38129" end="38140"/><chebi:Chemical xmi:id="1887" sofa="2182" begin="38169" end="38201"/><chebi:Chemical xmi:id="1892" sofa="2182" begin="38444" end="38448"/><chebi:Chemical xmi:id="1897" sofa="2182" begin="38618" end="38628"/><chebi:Chemical xmi:id="1902" sofa="2182" begin="38650" end="38661"/><chebi:Chemical xmi:id="1907" sofa="2182" begin="38841" end="38879"/><chebi:Chemical xmi:id="1912" sofa="2182" begin="38884" end="38896"/><chebi:Chemical xmi:id="1917" sofa="2182" begin="39115" end="39119"/><chebi:Chemical xmi:id="1922" sofa="2182" begin="39430" end="39440"/><chebi:Chemical xmi:id="1927" sofa="2182" begin="39514" end="39524"/><chebi:Chemical xmi:id="1932" sofa="2182" begin="39622" end="39625"/><chebi:Species xmi:id="1937" sofa="2182" begin="822" end="827"/><chebi:Species xmi:id="1942" sofa="2182" begin="1027" end="1032"/><chebi:Species xmi:id="1947" sofa="2182" begin="1516" end="1533"/><chebi:Species xmi:id="1952" sofa="2182" begin="1718" end="1723"/><chebi:Species xmi:id="1957" sofa="2182" begin="1901" end="1906"/><chebi:Species xmi:id="1962" sofa="2182" begin="1936" end="1941"/><chebi:Species xmi:id="1967" sofa="2182" begin="2745" end="2750"/><chebi:Species xmi:id="1972" sofa="2182" begin="2892" end="2897"/><chebi:Species xmi:id="1977" sofa="2182" begin="2916" end="2921"/><chebi:Species xmi:id="1982" sofa="2182" begin="2999" end="3007"/><chebi:Species xmi:id="1987" sofa="2182" begin="4879" end="4884"/><chebi:Species xmi:id="1992" sofa="2182" begin="5057" end="5062"/><chebi:Species xmi:id="1997" sofa="2182" begin="5116" end="5121"/><chebi:Species xmi:id="2002" sofa="2182" begin="6020" end="6025"/><chebi:Species xmi:id="2007" sofa="2182" begin="6053" end="6058"/><chebi:Species xmi:id="2012" sofa="2182" begin="6226" end="6231"/><chebi:Species xmi:id="2017" sofa="2182" begin="7052" end="7057"/><chebi:Species xmi:id="2022" sofa="2182" begin="7191" end="7196"/><chebi:Species xmi:id="2027" sofa="2182" begin="7966" end="7971"/><chebi:Species xmi:id="2032" sofa="2182" begin="8105" end="8110"/><chebi:Species xmi:id="2037" sofa="2182" begin="8528" end="8533"/><chebi:Species xmi:id="2042" sofa="2182" begin="8561" end="8566"/><chebi:Species xmi:id="2047" sofa="2182" begin="9676" end="9681"/><chebi:Species xmi:id="2052" sofa="2182" begin="9926" end="9931"/><chebi:Species xmi:id="2057" sofa="2182" begin="10057" end="10062"/><chebi:Species xmi:id="2062" sofa="2182" begin="13837" end="13842"/><chebi:Species xmi:id="2067" sofa="2182" begin="14288" end="14293"/><chebi:Species xmi:id="2072" sofa="2182" begin="14323" end="14328"/><chebi:Species xmi:id="2077" sofa="2182" begin="29168" end="29173"/><chebi:Species xmi:id="2082" sofa="2182" begin="30276" end="30281"/><chebi:Species xmi:id="2087" sofa="2182" begin="31436" end="31441"/><chebi:Species xmi:id="2092" sofa="2182" begin="32790" end="32795"/><chebi:Species xmi:id="2097" sofa="2182" begin="33161" end="33166"/><chebi:Species xmi:id="2102" sofa="2182" begin="33505" end="33510"/><chebi:Species xmi:id="2107" sofa="2182" begin="33596" end="33601"/><chebi:Species xmi:id="2112" sofa="2182" begin="33631" end="33636"/><chebi:Species xmi:id="2117" sofa="2182" begin="34223" end="34228"/><chebi:Species xmi:id="2122" sofa="2182" begin="35103" end="35120"/><chebi:Species xmi:id="2127" sofa="2182" begin="35343" end="35349"/><chebi:Species xmi:id="2132" sofa="2182" begin="35491" end="35508"/><chebi:Species xmi:id="2137" sofa="2182" begin="35925" end="35942"/><chebi:Species xmi:id="2142" sofa="2182" begin="36233" end="36250"/><chebi:Species xmi:id="2147" sofa="2182" begin="36491" end="36494"/><chebi:Species xmi:id="2152" sofa="2182" begin="36738" end="36762"/><chebi:Species xmi:id="2157" sofa="2182" begin="36979" end="36982"/><chebi:Species xmi:id="2162" sofa="2182" begin="37223" end="37238"/><chebi:Species xmi:id="2167" sofa="2182" begin="37243" end="37248"/><chebi:Species xmi:id="2172" sofa="2182" begin="38202" end="38207"/><chebi:Species xmi:id="2177" sofa="2182" begin="38900" end="38905"/><cas:Sofa xmi:id="2182" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 1&#10;&#10;ORIGINAL RESEARCH&#10;published: 22 February 2018&#10;&#10;doi: 10.3389/fphar.2018.00130&#10;&#10;Edited by:&#10;Judith Maria Rollinger,&#10;&#10;University of Vienna, Austria&#10;&#10;Reviewed by:&#10;Marinella De Leo,&#10;&#10;Università degli Studi di Pisa, Italy&#10;Xiaoying Zhang,&#10;&#10;Northwest A&amp;F University, China&#10;Marc Poirot,&#10;&#10;Institut National de la Santé et de la&#10;Recherche Médicale (INSERM),&#10;&#10;France&#10;&#10;*Correspondence:&#10;Qingwang Liu&#10;&#10;liuqingwang312@163.com&#10;Jie Yuan&#10;&#10;dsyuanjie@126.com&#10;&#10;Specialty section:&#10;This article was submitted to&#10;&#10;Ethnopharmacology,&#10;a section of the journal&#10;&#10;Frontiers in Pharmacology&#10;&#10;Received: 29 November 2017&#10;Accepted: 06 February 2018&#10;Published: 22 February 2018&#10;&#10;Citation:&#10;Zhang Z, Fang T, Zhou H, Yuan J&#10;and Liu Q (2018) Characterization&#10;&#10;of the in Vitro Metabolic Profile&#10;of Evodiamine in Human Liver&#10;&#10;Microsomes and Hepatocytes by&#10;UHPLC-Q Exactive Mass&#10;&#10;Spectrometer.&#10;Front. Pharmacol. 9:130.&#10;&#10;doi: 10.3389/fphar.2018.00130&#10;&#10;Characterization of the in Vitro&#10;Metabolic Profile of Evodiamine&#10;in Human Liver Microsomes and&#10;Hepatocytes by UHPLC-Q Exactive&#10;Mass Spectrometer&#10;Zhaowei Zhang1, Tianzi Fang1, Hongyun Zhou1, Jie Yuan2* and Qingwang Liu3*&#10;&#10;1 Department of Pharmacy, Jinhua Municipal Central Hospital, Jinhua, China, 2 Anhui Provincial Institute for Food and Drug&#10;Control, Hefei, China, 3 Institute of Technology Innovation, Hefei Institutes of Physical Science, Chinese Academy of&#10;Sciences, Hefei, China&#10;&#10;Evodiamine is an indoloquinazoline alkaloid isolated from the fruit of Evodia rutaecarpa,&#10;which has a wide range of pharmacological effects like anti-tumor and anti-inflammatory&#10;effects. This study was intended to investigate the metabolic characteristics of&#10;evodiamine in human liver microsomes and hepatocytes by ultra-high performance&#10;liquid chromatography coupled with a Q Exactive mass spectrometer. A total of 12&#10;phase I metabolites were detected in human liver microsomes; whereas in human&#10;hepatocytes 19 metabolites, including seven phase II metabolites were detected. The&#10;structures of the metabolites were characterized based on their accurate masses,&#10;fragment ions, and chromatographic retention times. Four metabolites (M1, M2,&#10;M5, and M7) were further unambiguously confirmed by matching their retention&#10;times, accurate masses, and fragment ions with those of their reference standards.&#10;Among these metabolites, 12 metabolites are first identified (M2, M5–M8, M10–&#10;M13, and M17–M19). The current study revealed that oxygenation, N-demethylation,&#10;dehydrogenation, glucuronidation, and GSH conjugation were the major metabolic&#10;pathways for evodiamine. This study elucidated the detailed metabolite profiles of&#10;evodiamine, which is helpful in predicting in vivo metabolism of evodiamine in human and&#10;in understanding the elimination mechanism of evodiamine and in turn, the effectiveness&#10;and toxicity.&#10;&#10;Keywords: evodiamine, metabolism, human liver microsomes, human hepatocytes, LC-MS&#10;&#10;INTRODUCTION&#10;&#10;Evodia rutaecarpa (Juss.) Benth (family of Rutaceae) has been widely used for medicinal purposes&#10;in China for treatment of aches and gastrointestinal disorders for thousands of years (Chinese&#10;Pharmacopoeia Commission, 2010). Evodiamine (Figure 1), an indoloquinazoline alkaloid isolated&#10;from the fruit of E. rutaecarpa, was found as one of the main active components in this herb&#10;medicine. Evodiamine has been reported to function as anti-inflammatory (Chiou et al., 1997;&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 1 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 2&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;Ko et al., 2007), vasodilatory (Chiou et al., 1996), and anti-obesity&#10;agent (Kobayashi et al., 2001). Recently, evodiamine has drawn&#10;increasing attention due to its anti-tumor activity by inhibiting&#10;proliferation of various cancer cell lines (Liao et al., 2005; Jiang&#10;and Hu, 2009), by inducing apoptosis (Zhang et al., 2004), and by&#10;inhibiting topoisomerases I and II (Pan et al., 2012).&#10;&#10;Previous pharmacokinetic study demonstrated that&#10;evodiamine showed very low oral bioavailability (Komatsu et al.,&#10;1993), which may be attributed to the extensive metabolism.&#10;Komatsu et al. (1993) have reported that evodiamine could be&#10;rapidly converted to its metabolites (see also Lee et al., 2017),&#10;and its metabolite 10-hydroxyevodiamine showed stronger&#10;cytotoxicity than evodiamine (Li et al., 2006). Wen et al. (2014)&#10;reported that evodiamine undergo metabolic bioactivation&#10;to form its reactive metabolites, and evodiamine is a time-&#10;dependent inhibitor of CYP3A4. These results indeed provided&#10;some clues in interpreting the mechanism of hepatotoxicity of&#10;evodiamine. Although several studies referred to the metabolism&#10;of evodiamine have been reported (Sun et al., 2013; Wen et al.,&#10;2014), detailed metabolite profiling of evodiamine, especially&#10;in human, has not been carried out. Detailed metabolite&#10;information is helpful to understand the mechanism of drug&#10;action.&#10;&#10;In early drug discovery stage, it is hard to get in vivo&#10;human metabolism data due to the ethics and safety issues.&#10;Human liver microsomes and hepatocytes are alternatives. Liver&#10;microsomes are the most widely used for drug metabolism&#10;studies as they are easy to handle and commercially available.&#10;However, there are few limitations (Basu and Shaik, 2016).&#10;For example, liver microsomes lack the cell membranes to&#10;mimic the physiological environment in hepatocytes. In&#10;addition, they have to be supplemented with cofactors such&#10;as reduced nicotinamide adenine dinucleotide phosphate&#10;(NADPH) or uridine 5′-diphosphate glucuronic acid. By&#10;contrast, hepatocytes are more suitable for metabolism study&#10;as they overcome the limitations above and they represent&#10;a more complete system to study drug phase I and phase II&#10;metabolism (Shaik, 2016). However, their application is to&#10;some extent limited because they are not readily available and&#10;difficult to reproduce the results due to high inter individual&#10;variability between human liver donors. In practice, human liver&#10;microsomes and hepatocytes are both applied for evaluating drug&#10;metabolism liability in order to get more detailed metabolism&#10;information for predicting in vivo human metabolite. Metabolite&#10;characterization continues to be a challenge for scientists.&#10;&#10;FIGURE 1 | Chemical structure of evodiamine.&#10;&#10;Ultra-high performance liquid chromatography coupled with&#10;Q (UHPLC-Q) Exactive Orbitrap mass spectrometer was&#10;demonstrated to be one of the most reliable techniques for&#10;metabolites characterization, which can provide accurate&#10;masses of metabolites and data dependent MS2 fragment&#10;ions for credible structural analysis (Lopez-Gutierrez et al.,&#10;2014; Scheidweiler and Huestis, 2014). The data processing&#10;software Metworks can easily find the potential metabolites&#10;according to mass defect filter (MDF) function and background&#10;subtraction program, which facilitates the identification of&#10;metabolites.&#10;&#10;The current work aimed to identify the metabolite following&#10;incubation of evodiamine with human liver microsomes and&#10;hepatocytes by using UHPLC-Q Exactive mass spectrometer, and&#10;to propose the metabolic pathways of evodiamine in human.&#10;A total of 19 metabolites, including seven phase II metabolites,&#10;were detected and identified. Oxygenation, N-demethylation,&#10;GSH conjugation, and glucuronidation were the predominant&#10;metabolic pathways of evodiamine.&#10;&#10;MATERIALS AND METHODS&#10;&#10;Chemicals and Reagents&#10;Evodiamine with purity &gt;98% was purchased from&#10;Shanghai PureOne BioTech Co., Ltd. (Shanghai, China).&#10;10-Hydroxyevodiamine with purity &gt;98% was purchased&#10;from Chengdu Herbpurify Co., Ltd. (Chengdu, China).&#10;3-Hydroxyevodiamine, 3-hydroxyevodiamine glucuronide, and&#10;10-hydroxyevodiamine glucuronide with the purity more than&#10;97.5% were presented as a gift by Dr. Chunyong He and their&#10;structures were confirmed by high-resolution mass spectrometry&#10;and nuclear magnetic resonance spectroscopy. Cryopreserved&#10;human hepatocytes (20 donors) were purchased from the&#10;Research Institute for Liver Diseases (Shanghai) Co., Ltd.&#10;(Shanghai, China). Pooled human liver microsomes (20 donors)&#10;were purchased from BD Gentest (Woburn, MA, United States).&#10;NADPH and MgCl2·6H2O were purchased from Sigma–Aldrich&#10;(St. Louis, MO, United States). Deionized water was generated&#10;from Milli-Q Water Millipore Purification System (Millipore&#10;Corp., Bedford, MA, United States). All other chemicals and&#10;reagents were of analytical grade and commercially available.&#10;&#10;Metabolism of Evodiamine in Human&#10;Hepatocytes&#10;Suspensions of human hepatocytes (1× 106 cell/ml) in Williams’&#10;E medium were incubated for 2 h with 0.2% acetonitrile (control)&#10;or 10 µM evodiamine, rotating at 150 rpm at 37◦C in an&#10;incubator at 5% CO2 and 95% humidity. The total volume of&#10;incubation was 200 µl. Viability of hepatocytes at pre-incubation&#10;and post-incubation were determined by trypan blue exclusion&#10;test and the viability was more than 80%. After incubation for&#10;2 h, the biotransformation was terminated by adding 400 µl of&#10;acetonitrile, and then the samples were centrifuged at 12,000 rpm&#10;for 10 min. The resulting supernatant was evaporated to dryness&#10;under nitrogen gas at room temperature, and the residue was&#10;reconstituted with 200 µl of 20% acetonitrile. The sample was&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 2 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 3&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;centrifuged at 12,000 rpm for 10 min. The resulting supernatant&#10;was transferred into a clear Eppendorf tube, and an aliquot of 5 µl&#10;was analyzed by LC/MS.&#10;&#10;Metabolism of Evodiamine in Pooled&#10;Human Liver Microsomes&#10;All incubations were performed at 37◦C in an incubator at&#10;5% CO2 and 95% humidity. Stock solution of evodiamine was&#10;prepared in acetonitrile. The final concentration of acetonitrile&#10;in the incubation was 0.2% (v/v). The pooled human liver&#10;microsomes were carefully thawed on ice before experiment.&#10;Metabolism of evodiamine (10 µM) was performed using pooled&#10;human liver microsomes in 100 mM potassium phosphate&#10;buffer (pH 7.4), and the microsomal protein concentration&#10;was set at 0.5 mg/ml. After a 5-min pre-incubation at&#10;37◦C, the reactions were initiated by addition of cofactor&#10;solution containing 1.0 mM NADPH and 3.0 mM MgCl2.&#10;The total incubation volume was 400 µl. After incubation&#10;for 60 min, the reactions were terminated by adding 800 µl&#10;of acetonitrile, and then the samples were centrifuged at&#10;12,000 rpm for 10 min. The resulting supernatant was&#10;evaporated to dryness under nitrogen gas at room temperature,&#10;and the residue was reconstituted with 200 µl of 20%&#10;acetonitrile. The sample was centrifuged at 12,000 rpm for&#10;10 min. The resulting supernatant was then transferred into&#10;a clear Eppendorf tube, and a 5 µl portion was analyzed by&#10;LC/MS.&#10;&#10;UHPLC-Q Exactive Mass Spectrometer&#10;Conditions&#10;The LC system consisted of a Thermo Dionex U3000&#10;UHPLC system (Thermo Electron Corporation, San Jose, CA,&#10;United States), and chromatographic separations were carried&#10;out on an ACQUITY UPLC BEH C18 column (2.1 mm× 50 mm,&#10;i.d., 1.7 µm) thermostated at 40◦C. The mobile phase consisted of&#10;0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile&#10;(B), at the flow rate of 0.3 ml/min. The gradient elution program&#10;was set as follow: 0–1 min, 10% B; 1–5 min, 10–40% B; 5–11 min,&#10;40-55% B; 11–14 min, 55–90% B; 14–16 min, 90% B; and finally,&#10;the column was equilibrated with 10% B for 2 min. The sampler&#10;was kept at 10◦C and the injection volume was 5 µl.&#10;&#10;High-resolution MS and MS2 spectra were obtained on&#10;a Q-Exactive Orbitrap mass spectrometer (Thermo Electron&#10;Corporation, San Jose, CA, United States) equipped with an&#10;electrospray ionization interface operated in positive ion mode.&#10;The optimized parameters were set as follow: capillary voltage,&#10;3.0 kV; sheath gas flow rate, 35 arbitrary unit; auxiliary gas&#10;flow rate, 5 arbitrary unit; sweep gas flow rate, 5 arbitrary unit;&#10;capillary temperature, 325◦C; sheath gas heater temperature,&#10;200◦C. Data were acquired from 100 to 1000 Da with dd-MS2 or&#10;MS2 in centroid mode with ramp collision energy being set at 30,&#10;35, and 45 eV. Raw data were acquired and processed using the&#10;Xcalibur software (Version 2.3.1, Thermo Electron Corporation,&#10;San Jose, CA, United States). Metworks software was used&#10;for post-acquisition data processing, which can automatically&#10;generate a list of proposed metabolites by comparing the LC/MS&#10;&#10;chromatograms of the drug-containing sample with the control&#10;samples according to MDF function.&#10;&#10;RESULTS AND DISCUSSION&#10;&#10;Fragmentation of Evodiamine Standard&#10;In order to facilitate the structural identification of metabolites,&#10;the MS2 fragmentation behaviors of evodiamine was investigated&#10;by using UHPLC-Q Exactive mass spectrometer, which can&#10;provide accurate mass, element composition, and the error&#10;between calculated mass and measured mass. Evodiamine&#10;showed protonated ion [M+H]+ at m/z 304.1431 (−4.3 ppm,&#10;C19H18N3O) and produced a series of product ions in&#10;product ion scan. As shown in MS2 spectrum (Figure 2A),&#10;evodiamine showed characteristic product ions at m/z 276.1477,&#10;171.0908, 161.0701, 144.0801, 134.0594, and 106.0649. The&#10;proposed fragmentation pathways of evodiamine were presented&#10;in Figure 2B. Among of them, the fragment ions at m/z&#10;134.0594 and 171.0908 were attributed to the cleavage between&#10;the 2-aminobenzaldehyde and carboline moieties to form&#10;a benzoisoxazole after rearrangement. The fragment ions&#10;at m/z 161.0701 and 144.0801 were likely generated from&#10;ring fission through retro-Diels–Alder reaction followed by&#10;cleavage of C–N bond. The product ion at m/z 276.1477&#10;was derived from the protonated ion m/z 304.1431 by loss&#10;of CO.&#10;&#10;LC/MS Analysis of Metabolites of&#10;Evodiamine&#10;In vitro metabolites of evodiamine in human liver microsomes&#10;and hepatocytes were analyzed using LC/MS. The difference&#10;analysis between blank and evodiamine-containing incubation&#10;sample was performed by Metworks software (Thermo Electron&#10;Corporation, San Jose, CA, United States). Precursor ions&#10;specifically found in evodiamine-containing incubation samples&#10;were viewed as potential metabolites and were thus conducted&#10;for MS2 analysis. A total of 12 phase I metabolites were&#10;detected in human liver microsomes; whereas in human&#10;hepatocytes a total of 19 metabolites, including 7 phase II&#10;metabolites, were detected and identified. The extracted ion&#10;chromatograms of these metabolites are shown in Figure 3.&#10;The retention times, measured and theoretical masses, mass&#10;errors, and characteristic fragment ions of the proposed&#10;metabolites are summarized in Table 1. The maximum&#10;mass errors between the measured and theoretical values&#10;were within 5 ppm. The structures of metabolites were&#10;characterized based on their accurate masses, fragment ions,&#10;and retention times, and four metabolites (M1, M2, M5,&#10;and M7) were further confirmed by matching their retention&#10;times, accurate masses, and fragment ions with their reference&#10;standards.&#10;&#10;Metabolites M1 and M2&#10;M1 and M2, eluted at the retention times of 6.27 and 7.56 min,&#10;respectively, showed an accurate protonated molecular&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 3 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 4&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;FIGURE 2 | MS2 spectrum of evodiamine (A) and its fragmentation pathways (B) in positive ion mode.&#10;&#10;ion at m/z 320.1395 (calculated 320.1394), 15.9964 Da&#10;higher than that of evodiamine, suggesting that M1 and&#10;M2 were oxygenation metabolites of evodiamine. MS2&#10;spectrum of M1, as shown in Figure 4A, displayed a typical&#10;product ion at m/z 187.0851, suggesting that oxygenation&#10;&#10;occurred at carboline moiety. The other fragment ions&#10;at m/z 161.0693, 160.0745, and 134.0591 suggested that&#10;the 2-aminobenzaldehyde moiety remained unmodified.&#10;Compared with reference standard, the retention time,&#10;accurate mass, and product ions of M1 were identical to&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 4 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 5&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;FIGURE 3 | Extracted ion chromatograms of metabolites of evodiamine.&#10;&#10;those of 10-hydroxyevodiamine. Hence, M1 was identified as&#10;10-hydroxyevodiamine.&#10;&#10;MS2 spectrum of M2 (Figure 4B) showed typical product&#10;ions at m/z 177.0676, 150.0539, and 122.0594, indicating that&#10;oxygenation occurred at the 2-aminobenzaldehyde moiety. The&#10;other fragment ions at m/z 171.0903 and 144.0797 were&#10;identical to those of parent, which suggested that carboline&#10;moiety remained intact. Compared with reference standard, the&#10;retention time, accurate mass and product ions of M2 were&#10;identical to those of 3-hydroxyevodiamine. Hence, M2 was&#10;identified as 3-hydroxyevodiamine.&#10;&#10;Metabolites M3 and M4&#10;M3 and M4 were eluted at 4.78 and 4.90 min, respectively.&#10;Both metabolites showed an accurate protonated molecular ion&#10;at m/z 625.2045 (calculated 625.2075), 321.0614 Da higher than&#10;that of evodiamine, suggesting that M3 and M4 were formed by&#10;oxygenation followed by GSH conjugation of evodiamine. MS2&#10;spectra of M3 and M4 (Figure 4C) showed typical product ions&#10;at m/z 550.1699 and 496.1601, which were derived from neutral&#10;loss of glutamate residue (−129.0444 Da) and glycine residue&#10;(−75.0346 Da), respectively (Wen and Zhu, 2015). The product&#10;ions at m/z 492.1512, 363.1094, 336.0985, 219.0587, and 192.0463&#10;demonstrated that oxygenation and GSH conjugation occurred at&#10;carboline moiety. It has been well-known that 5-hydroxyindole&#10;can form reactive species quinone-imine and this intermediate&#10;&#10;was readily conjugated with GSH (Figure 5A). Compared with&#10;previous report (Wen et al., 2014), M3 and M4 were therefore&#10;identified as GSH conjugates of M1.&#10;&#10;Metabolite M5&#10;M5 was eluted at 5.12 min with accurate protonated molecular&#10;ion at m/z 496.1722 (calculated 496.1714), 192.0291 Da&#10;higher than that of parent, suggesting that M5 was formed&#10;by oxygenation followed by glucuronide conjugation of&#10;evodiamine. MS2 spectrum, as shown in Figure 4D, displayed&#10;a characteristic product ion at m/z 320.1394 which was&#10;formed via neutral loss of glucuronyl (−176.0328 Da).&#10;Product ions at m/z 363.1160, 187.0850, and 134.0591&#10;suggested that oxygenation and glucuronidation occurred&#10;at carboline moiety. Compared with reference standard, the&#10;retention time, accurate mass, and product ions of M5 were&#10;identical to those of 10-hydroxyevodiamine glucuronide.&#10;M5 was hence identified as glucuronide conjugate of&#10;10-hydroxyevodiamine (M1).&#10;&#10;Metabolite M6&#10;M6 was eluted at 4.69 min with an accurate protonated&#10;molecular ion at m/z 336.1343 (calculated 336.1343),&#10;31.9912 Da higher than that of parent, suggesting that M6&#10;was the di-oxygenation metabolite of evodiamine. MS2&#10;spectrum of this precursor ion (Figure 6A) showed typical&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 5 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 6&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;TABLE 1 | Characterization of in vitro metabolites of evodiamine by UHPLC-Q Exactive mass spectrometer.&#10;&#10;Metabolites No. RT (min) Mass shift Theo. m/z Meas. m/z Error (ppm) Fragment ions Metabolic pathways&#10;&#10;M1 6.27 15.9949 320.1394 320.1395 0.3 187.0851, 161.0693,&#10;160.0745, 134.0591&#10;&#10;Oxygenation (P + O)&#10;&#10;M2 7.56 15.9949 320.1394 320.1395 0.3 177.0646, 171.0903,&#10;150.0539, 144.0797,&#10;122.0597&#10;&#10;Oxygenation (P + O)&#10;&#10;M3 4.78 321.0631 625.2075 625.2045 −4.8 550.1699, 496.1601,&#10;492.1512, 363.1094,&#10;336.0985, 219.0587,&#10;192.0463, 134.0591&#10;&#10;Oxygenation and GSH conjugation&#10;(P + O + C10H15N3O6S)&#10;&#10;M4 4.90 321.0631 625.2075 625.2045 −4.8 550.1699, 496.1601,&#10;492.1512, 363.1094,&#10;336.0985, 219.0587,&#10;192.0463, 134.0591&#10;&#10;Oxygenation and GSH conjugation&#10;(P + O + C10H15N3O6S)&#10;&#10;M5 5.12 192.0270 496.1714 496.1722 1.6 363.1160, 320.1394,&#10;187.0850, 134.0591&#10;&#10;Oxygenation and glucuronidation&#10;(P + O + C6H8O6)&#10;&#10;M6 4.69 31.9898 336.1343 336.1343 0.0 318.1239,177.0645,&#10;160.0745, 150.0538,&#10;144.0797&#10;&#10;Di-oxygenation (P + 2O)&#10;&#10;M7 6.19 192.0270 496.1714 496.1722 1.6 344.0949, 326.0846,&#10;320.1368, 171.0903,&#10;150.0538, 144.0796&#10;&#10;Oxygenation and glucuronidation&#10;(P + O + C6H8O6)&#10;&#10;M8 6.61 1.9793 306.1237 306.1241 1.3 171.0905, 144.0799,&#10;136.0384&#10;&#10;N-demethylation and oxygenation&#10;(P − CH2 + O)&#10;&#10;M9 6.09 15.9949 320.1394 320.1395 0.3 187.0851, 161.0693,&#10;160.0745, 134.0591&#10;&#10;Oxygenation (P + O)&#10;&#10;M10 5.48 192.0270 496.1714 496.1722 1.6 363.1160, 320.1394,&#10;187.0854, 134.0590&#10;&#10;Oxygenation and glucuronidation&#10;(P + O + C6H8O6)&#10;&#10;M11 4.07 31.9898 336.1343 336.1331 −3.6 318.1239, 176.0693,&#10;161.0697, 134.0591&#10;&#10;Di-oxygenation (P + 2O)&#10;&#10;M12 6.29 29.9742 334.1186 334.1177 −2.7 174.0537, 161.0697,&#10;134.0592&#10;&#10;Di-oxygenation and dehydrogenation&#10;(P + 2O − 2H)&#10;&#10;M13 5.41 31.9898 336.1343 336.1341 −0.6 187.0851, 176.0693,&#10;161.0697, 134.0591&#10;&#10;Di-oxygenation (P + 2O)&#10;&#10;M14 5.00 305.0682 609.2126 609.2125 −0.2 480.1305, 308.0887,&#10;302.1264, 179.0472&#10;&#10;GSH conjugation (P + C10H15N3O6S)&#10;&#10;M15 5.21 305.0682 609.2126 609.2125 −0.2 480.1305, 308.0887,&#10;302.1264, 179.0472&#10;&#10;GSH conjugation (P + C10H15N3O6S)&#10;&#10;M16 7.69 −14.0157 290.1288 290.1281 −2.4 171.0905, 144.0799,&#10;120.0436&#10;&#10;N-demethylation (P − CH2)&#10;&#10;M17 4.76 1.9793 306.1237 306.1241 1.3 187.0852, 160.0745,&#10;120.0437&#10;&#10;N-demethylation and oxygenation&#10;(P − CH2 + O)&#10;&#10;M18 5.49 1.9793 306.1237 306.1241 1.3 187.0852, 160.0745,&#10;120.0437&#10;&#10;N-demethylation and oxygenation&#10;(P − CH2 + O)&#10;&#10;M19 5.74 1.9793 306.1237 306.1241 1.3 187.0852, 160.0745,&#10;120.0437&#10;&#10;N-demethylation and oxygenation&#10;(P − CH2 + O)&#10;&#10;Evodiamine 8.85 0.0000 304.1444 304.1431 −4.3 276.1477, 171.0908,&#10;161.0701, 144.0801,&#10;134.0594, 106.0649&#10;&#10;Parent&#10;&#10;P, parent (evodiamine); Mass shift, mass different between metabolite and parent (evodiamine); Theo. m/z, theoretical mass charge ratio; Meas. m/z, measured mass&#10;charge ratio.&#10;&#10;product ions at m/z 177.0645 and 150.0538, which suggested&#10;that one oxygenation occurred at 2-aminobenzaldehyde&#10;moiety. Considering that C-3 of evodiamine was readily&#10;hydroxylated, this oxygenation was likely to occur at C-&#10;3 position. Product ion at m/z 160.0745 suggested that&#10;other oxygenation occurred at carboline moiety. A minor&#10;product ion at m/z 318.1239 was formed by loss of&#10;H2O (−18.0104 Da) from precursor ion, which further&#10;&#10;demonstrated that oxygenation occurred at C-8 position&#10;of evodiamine. Therefore, M6 was derived from M2 via&#10;oxygenation.&#10;&#10;Metabolite M7&#10;M7 was eluted at 6.19 min with an accurate protonated&#10;molecular ion atm/z 496.1722 (calculated 496.1714), 192.0291 Da&#10;higher than that of parent, suggesting that M7 was formed by&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 6 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 7&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;FIGURE 4 | MS2 spectra of M1 (A), M2 (B), M3, and M4 (C), and M5 (D).&#10;&#10;FIGURE 5 | Formation of M3 and M4 (A) and M14 and M15 (B).&#10;&#10;oxygenation followed by glucuronide conjugation of evodiamine.&#10;MS2 spectrum of this precursor ion (Figure 6B) showed&#10;a characteristic product ion at m/z 320.1368, which was&#10;formed through neutral loss of glucuronyl (−176.0354 Da).&#10;Product ions at m/z 344.0949, 326.0846, 171.0903, and 150.0538&#10;suggested that oxygenation and glucuronidation occurred&#10;at 2-aminobenzaldehyde moiety, and the carboline moiety&#10;remained unmodified. Compared with reference standard,&#10;the retention time, accurate mass and product ions of M7&#10;were identical to those of 3-hydroxyevodiamine glucuronide.&#10;M7 was hence identified as glucuronide conjugate of 3-&#10;hydroxyevodiamine (M2).&#10;&#10;Metabolite M8&#10;M8 was eluted at 6.61 min with an accurate protonated&#10;molecular ion at m/z 306.1241 (calculated 306.1237), 1.9810 Da&#10;&#10;higher than that of parent, suggesting that M8 was formed by&#10;oxygenation and demethylation of evodiamine. MS2 spectrum&#10;(Figure 6C) showed a characteristic product ion at m/z&#10;171.0905 by loss of 2-aminobenzaldehyde moiety, suggesting&#10;that carboline moiety remained unmodified. Product ion at&#10;m/z 136.0384 proved that the oxygenation and demethylation&#10;occurred at 2-aminobenzaldehyde moiety. Considering that C-&#10;3 position of evodiamine was readily hydroxylated, M8 was&#10;tentatively formed from M2 via demethylation or from M16 via&#10;oxygenation.&#10;&#10;Metabolite M9&#10;M9 eluted at the retention time of 6.09 min showed an&#10;accurate protonated molecular ion at m/z 320.1395 (calculated&#10;320.1394), which was 15.9964 Da higher than that of parent,&#10;suggesting that M9 was oxygenation metabolite of evodiamine.&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 7 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 8&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;FIGURE 6 | MS2 spectra of M6 (A), M7 (B), M8 (C), and M9 (D).&#10;&#10;MS2 spectrum of M9 (Figure 6D) showed typical product ion at&#10;m/z 187.0851, suggesting that oxygenation occurred at carboline&#10;moiety. The other product ions at m/z 161.0693, 160.0745,&#10;and 134.0591 suggested that the 2-aminobenzaldehyde moiety&#10;remained unmodified. Hence, M9 was identified as oxygenation&#10;metabolite of evodiamine.&#10;&#10;Metabolite M10&#10;M10 was eluted at 5.48 min with an accurate protonated&#10;molecular ion atm/z 496.1722 (calculated 496.1714), 192.0291 Da&#10;higher than that of parent, suggesting that M10 was from&#10;oxygenation followed by glucuronide conjugation of parent.&#10;MS2 spectrum (Figure 7A) showed a characteristic neutral loss&#10;of glucuronyl (−176.0328 Da) to form product ion at m/z&#10;320.1394. Product ions at m/z 363.1160, 187.0854, and 134.0590&#10;suggested that oxygenation and glucuronidation occurred at&#10;carboline moiety. M10 was tentatively proposed as glucuronide&#10;conjugate of M9. This metabolic pathway was similar to&#10;that of rutaecarpine, an analog of evodiamine (Lee et al.,&#10;2017).&#10;&#10;Metabolite M11&#10;M11 was eluted at 4.07 min with an accurate protonated&#10;molecular ion at m/z 336.1331 (calculated 336.1343), 31.9900 Da&#10;higher than that of parent, suggesting that M11 was derived&#10;from the di-oxygenation of parent. MS2 spectrum (Figure 7B)&#10;showed typical product ions at m/z 161.0697 and 134.0591,&#10;which suggested that 2-aminobenzaldehyde moiety remained&#10;intact. Product ion m/z 176.0693 indicated that di-oxygenation&#10;occurred at carboline moiety. A minor product ion at m/z&#10;318.1239 was formed through loss of H2O (−18.0092 Da) from&#10;&#10;precursor ion, which further demonstrated that oxygenation&#10;occurred at C-8 position of evodiamine. Therefore, M11 was&#10;tentatively identified as the oxygenation metabolite of M1&#10;or M9.&#10;&#10;Metabolite M12&#10;M12 was eluted at 6.29 min with an accurate protonated&#10;molecular ion at m/z 334.1177 (calculated 334.1186), 29.9746 Da&#10;higher than that of parent, suggesting that M12 was derived&#10;from the di-oxygenation and dehydrogenation of parent.&#10;MS2 spectrum (Figure 7C) showed typical product ions&#10;at m/z 161.0697 and 134.0592, which suggested that 2-&#10;aminobenzaldehyde moiety remained unmodified. Product ion&#10;m/z 174.0537 indicated that di-oxygenation and dehydrogenation&#10;occurred at carboline moiety. Therefore, M12 was identified as&#10;dehydrogenation product of M11.&#10;&#10;Metabolite M13&#10;M13 eluted at 5.41 min displayed an accurate protonated&#10;molecular ion at m/z 336.1341(calculated 336.1343), 31.9910 Da&#10;higher than that of parent, suggesting that M13 was from&#10;the di-oxygenation of parent. MS2 spectrum (Figure 7D)&#10;showed typical product ions at m/z 161.0697 and 134.0591,&#10;which suggested that 2-aminobenzaldehyde moiety remained&#10;unmodified. Product ion m/z 176.0693 indicated that di-&#10;oxygenation occurred at 3-methyleneindole moiety. A minor&#10;product ion at m/z 320.1365 was formed through loss of&#10;oxygen atom (−15.9976 Da) from precursor ion, which was&#10;a characteristic neutral loss of N-oxygenation metabolite.&#10;Therefore, M13 was tentatively identified as the N-oxygenation&#10;metabolite of M1 or M9.&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 8 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 9&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;FIGURE 7 | MS2 spectra of M10 (A), M11 (B), M12 (C), and M13 (D).&#10;&#10;FIGURE 8 | MS2 spectra of M14 and M15 (A), M16 (B), and M17–M19 (C).&#10;&#10;Metabolites M14 and M15&#10;M14 and M15 were eluted at 5.00 and 5.21 min, respectively.&#10;Both metabolites showed an accurate protonated molecular&#10;ion at m/z 609.2125 (calculated 609.2126), 305.0694 Da higher&#10;than that of parent, suggesting that M14 and M15 were&#10;GSH conjugate of parent. MS2 spectra of M14 and M15&#10;(Figure 8A) showed typical product ions at m/z 480.1305 and&#10;&#10;302.1264, which were derived from neutral loss of glutamate&#10;residue (−129.0820 Da) and GSH residue (−307.0861 Da)&#10;(Wen and Zhu, 2015). Therefore, M14 and M15 were identified&#10;to be GSH conjugate of parent. Their formation may be&#10;through oxidation of 3-methyleneindole to form imine-methide&#10;intermediate, followed by conjugation with GSH as shown in&#10;Figure 5B.&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 9 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 10&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;FIGURE 9 | Proposed metabolic pathways of evodiamine in human hepatocytes and liver microsomes.&#10;&#10;Metabolite M16&#10;M16 was eluted at 7.69 min with an accurate protonated&#10;molecular ion at m/z 290.1281 (calculated 290.1288), 14.0150 Da&#10;lower than that of parent, suggesting that M16 was the&#10;N-demethylation metabolite of evodiamine. MS2 spectrum&#10;(Figure 8B) showed typical product ions at m/z 171.0905 and&#10;144.0799, which were identical to those of parent. Product ion at&#10;m/z 120.0436 further proved that M16 was the N-demethylation&#10;metabolite of parent (Sun et al., 2013).&#10;&#10;Metabolite M17–M19&#10;M17, M18, and M19 were eluted at 4.76, 5.49, and 5.74 min,&#10;respectively. They all showed an exact protonated molecular&#10;ion at m/z 306.1241 (calculated 306.1237), 15.9960 Da higher&#10;than that of M16, suggesting that these metabolites were derived&#10;from oxygenation of M16. MS2 spectrum (Figure 8C) showed&#10;characteristic product ions at m/z 187.0852 and 160.0745,&#10;suggesting that oxygenation occurred at 3-methyleneindole&#10;moiety. Therefore, M17, M18, and M19 were identified as&#10;oxygenation products of M16.&#10;&#10;In Vitro Metabolism of Evodiamine&#10;In vitro metabolism of evodiamine in human liver microsomes&#10;and hepatocytes were investigated using UHPLC-Q Exactive&#10;mass spectrometer and the metabolic pathways were accordingly&#10;proposed, as shown in Figure 9. In general, the in vitro&#10;metabolism of evodiamine can be concluded to undergo four&#10;pathways. The first pathway is oxidation of indole moiety to&#10;form oxygenated metabolites M1 and M9, which undergo further&#10;&#10;metabolism to form GSH conjugates (M3 and M4) via reactive&#10;quinone-imine intermediate, to form glucuronide conjugates&#10;(M5 and M10), and to form di-oxygenation metabolites&#10;(M11 and M13). The second pathway is oxidation of C-&#10;3 position to form M2, which were further metabolized via&#10;oxygenation, glucuronidation and N-demethylation to form M6,&#10;M7, and M8, respectively. The third metabolic pathway is&#10;N-demethylation to form M16, which was further metabolized&#10;into oxygenated metabolites (M8, M17, M18, and M19).&#10;The fourth metabolic pathway is direct conjugation with&#10;GSH via reactive imine-methide intermediate to form GSH&#10;adducts (M14 and M15). Therefore, oxygenation, demethylation,&#10;GSH conjugation, and glucuronidation were the predominant&#10;metabolic pathways of evodiamine in human liver microsomes&#10;and hepatocytes.&#10;&#10;There are several literatures regarding metabolism of alkaloids&#10;from E. rutaecarpa (Li et al., 2006; Wen et al., 2014; Lee&#10;et al., 2017). Due the lack of references, the major metabolic&#10;sites were not assigned. Previous report by Wen et al. (2014)&#10;mainly focused on metabolic bioactivation of evodiamine. The&#10;author concluded that the formation of reactive metabolites&#10;is associated with the moderate hepatotoxicity of evodiamine.&#10;However, it lacks the overall metabolite profiles of evodiamine&#10;and the conclusion might be a little arbitrary because reactive&#10;metabolites do not always mean toxicity, such as cyclobenzaprine&#10;(Kalgutkar and Dalvie, 2015). The relationship between reactive&#10;metabolites and hepatotoxicity is very complex and hard to be&#10;established. A lot of factors can affect the hepatotoxicity, such&#10;as dose, multiple metabolic pathways, genetic polymorphism,&#10;and the amount of reactive metabolite in vivo. Sun et al. (2013),&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 10 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 11&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;identified several hydroxylated metabolites of evodiamine&#10;in vitro, but they missed the phase II metabolites. Our study&#10;provided detailed metabolite profiles of evodiamine in human&#10;liver microsomes and hepatocytes, leading to 12 new metabolites&#10;being identified (M2, M5–M8, M10–M13, and M17–M19).&#10;Our findings suggested that evodiamine undergo multiple&#10;metabolic pathways, which is helpful in understanding the&#10;mechanism of toxification and detoxification of evodiamine.&#10;Furthermore, our study provides valuable information in&#10;predicting in vivo human metabolite. Future study will be&#10;intended to focus on the covalent binding of evodiamine&#10;to protein and safety assessments of the newly identified&#10;metabolites.&#10;&#10;CONCLUSION&#10;&#10;In the present study, a rapid and reliable analytical method&#10;based on UHPLC-Q-Orbitrap-MS was developed and used&#10;for the identification of evodiamine metabolites in human&#10;liver microsomes and hepatocytes. A total of 12 phase I&#10;metabolites were detected in human liver microsomes; whereas&#10;in human hepatocytes a total of 19 metabolites, including&#10;seven phase II metabolites were detected. Four metabolites (M1,&#10;&#10;M2, M5, and M7) were further unambiguously confirmed by&#10;matching their retention times, accurate masses and fragment&#10;ions with their reference standards. Evodiamine was proved&#10;to be metabolized mainly via oxygenation, N-demethylation,&#10;glucuronidation, and GSH conjugation. Findings from the&#10;current work are helpful in understanding the mechanism of&#10;toxification and detoxification of evodiamine. Furthermore, our&#10;study provides valuable information in predicting in vivo human&#10;metabolites.&#10;&#10;AUTHOR CONTRIBUTIONS&#10;&#10;ZZ, JY, and QL conceived and designed the experiments. ZZ, TF,&#10;and HZ performed the experiments. ZZ, JY, and QL analyzed&#10;the data. ZZ and JY contributed reagents/materials/analysis tools.&#10;ZZ, JY, and QL wrote the paper.&#10;&#10;FUNDING&#10;&#10;This work was funded by medical and health research&#10;project of public health department of Zhejiang province (NO.&#10;2018258119).&#10;&#10;REFERENCES&#10;Basu, S., and Shaik, A. N. (2016). Is there a paradigm shift in use of microsomes and&#10;&#10;hepatocytes in drug discovery and development? ADMET DMPK 4, 114–116.&#10;doi: 10.5599/admet.4.2.317&#10;&#10;Chinese Pharmacopoeia Commission (2010). Pharmacopoeia of the People’s&#10;Republic of China, Vol. 1, Beijing: China Medical Science Press,&#10;160–161.&#10;&#10;Chiou, W. F., Liao, J. F., and Chen, C. F. (1996). Comparative study on vasodilatory&#10;effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J. Nat.&#10;Prod. 59, 374–378. doi: 10.1021/np960161+&#10;&#10;Chiou, W. F., Sung, Y. J., Liao, J. F., Shum, A. Y., and Chen, C. F. (1997). Inhibitory&#10;effect of dehydroevodiamine and evodiamine on nitric oxide production&#10;in cultured murine macrophages. J. Nat. Prod. 60, 708–711. doi: 10.1021/&#10;np960495z&#10;&#10;Jiang, J., and Hu, C. (2009). Evodiamine: a novel anti-cancer alkaloid from&#10;Evodia rutaecarpa. Molecules 14, 1852–1859. doi: 10.3390/molecules1405&#10;1852&#10;&#10;Kalgutkar, A. S., and Dalvie, D. (2015). Predicting toxicity of reactive metabolite-&#10;positive drug candidates. Annu. Rev. Pharmacol. Toxicol. 55, 35–54. doi: 10.&#10;1146/annurev-pharmtox-010814-124720&#10;&#10;Ko, H. C., Wang, Y. H., Liou, K. T., Chen, C. M., Chen, C. H., Wang,&#10;W. Y., et al. (2007). Anti-inflammatory effects and mechanisms of the ethanol&#10;extract of Evodia rutaecarpa and its bioactive components on neutrophils and&#10;microglial cells. Eur. J. Pharmacol. 555, 211–217. doi: 10.1016/j.ejphar.2006.&#10;10.002&#10;&#10;Kobayashi, Y., Nakano, Y., Kizaki, M., Honshikuma, K., Yokoo, Y., and Kamiya, T.&#10;(2001). Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia&#10;rutaecarpa, a vaniloid receptor agonist. Planta Med. 67, 628–633. doi: 10.1055/&#10;s-2001-17353&#10;&#10;Komatsu, K., Wakame, K., and Kano, Y. (1993). Pharmacological properties of&#10;galenical preparation. XVI. Pharmacokinetics of evodiamine and the metabolite&#10;in rat. Biol. Pharm. Bull. 16, 935–938. doi: 10.1248/bpb.16.935&#10;&#10;Lee, D. W., Kang, Y., Kang, M. J., Noh, K., Kim, J. H., Nepal, M. R., et al. (2017).&#10;Phase I and phase II metabolite identification of rutaecarpine in freshly isolated&#10;hepatocytes from male Sprague-Dawley rats. Arch. Pharm. Res. 40, 972–979.&#10;doi: 10.1007/s12272-017-0937-7&#10;&#10;Li, L., Liu, R., and Ye, M. (2006). Microbial metabolism of evodiamine by&#10;Penicillium janthinellum and its application for metabolite identification in&#10;rat urine. Enzyme Microb. Technol. 39, 561–567. doi: 10.1016/j.enzmictec.2005.&#10;10.029&#10;&#10;Liao, C. H., Pan, S. L., Guh, J. H., Chang, Y. L., Pai, H. C., Lin, C. H., et al. (2005).&#10;Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae&#10;fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells&#10;in vitro and in vivo. Carcinogenesis 26, 968–975. doi: 10.1093/carcin/bgi041&#10;&#10;Lopez-Gutierrez, N., Romero-Gonzalez, R., Frenich, A. G., and Vidal, J. L. M.&#10;(2014). Identification and quantification of the main isofiavones and other&#10;phytochemicals in soy based nutraceutical products by liquid chromatography-&#10;orbitrap high resolution mass spectrometry. J. Chromatogr. A 1348, 125–136.&#10;doi: 10.1016/j.chroma.2014.04.090&#10;&#10;Pan, X., Hartley, J. M., Hartley, J. A., White, K. N., Wang, Z., and&#10;Bligh, S. W. (2012). Evodiamine, a dual catalytic inhibitor of type I&#10;and II topoisomerases, exhibits enhanced inhibition against camptothecin&#10;resistant cells. Phytomedicine 19, 618–624. doi: 10.1016/j.phymed.2012.&#10;02.003&#10;&#10;Scheidweiler, K. B., and Huestis, M. A. (2014). Simultaneous quantification of 20&#10;synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl&#10;hydroxyl metabolites in human urine by liquid chromatography-tandem mass&#10;spectrometry. J. Chromatogr. A 1327, 105–117. doi: 10.1016/j.chroma.2013.&#10;12.067&#10;&#10;Shaik, A. N. (2016). Changing trends in use of hepatocytes and microsomes for&#10;evaluating metabolism studies in drug discovery. ADMET DMPK 4, 60–61.&#10;doi: 10.5599/admet.4.2.320&#10;&#10;Sun, H. Z., Fang, Z. Z., Cao, Y. F., Sun, X. Y., and Hong, M. (2013). Investigation of&#10;in vitrometabolism of evodiamine: characterization of metabolites and involved&#10;cytochrome P450 isoforms. Phytother. Res. 27, 705–712. doi: 10.1002/ptr.&#10;4766&#10;&#10;Wen, B., Roongta, V., Liu, L. L., and Moore, D. J. (2014). Metabolic activation of&#10;the indoloquinazoline alkaloids evodiamine and rutaecarpine by human liver&#10;microsomes: dehydrogenation and inactivation of cytochrome P450 3A4s. Drug&#10;Metab. Dispos. 42, 1044–1054. doi: 10.1124/dmd.114.057414&#10;&#10;Wen, B., and Zhu, M. S. (2015). Applications of mass spectrometry in drug&#10;metabolism: 50 years of progress. Drug Metab. Rev. 47, 71–87. doi: 10.3109/&#10;03602532.2014.1001029&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 11 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;fphar-09-00130 February 21, 2018 Time: 17:55 # 12&#10;&#10;Zhang et al. In Vitro Metabolism of Evodiamine&#10;&#10;Zhang, Y., Wu, L. J., Tashiro, S., Onodera, S., and Ikejima, T. (2004). Evodiamine&#10;induces tumor cell death through two different pathways: apoptosis and&#10;necrosis. Acta Pharmacol. Sin. 25, 83–89.&#10;&#10;Conflict of Interest Statement: The authors declare that the research was&#10;conducted in the absence of any commercial or financial relationships that could&#10;be construed as a potential conflict of interest.&#10;&#10;Copyright © 2018 Zhang, Fang, Zhou, Yuan and Liu. This is an open-access article&#10;distributed under the terms of the Creative Commons Attribution License (CC BY).&#10;The use, distribution or reproduction in other forums is permitted, provided the&#10;original author(s) and the copyright owner are credited and that the original&#10;publication in this journal is cited, in accordance with accepted academic practice.&#10;No use, distribution or reproduction is permitted which does not comply with these&#10;terms.&#10;&#10;Frontiers in Pharmacology | www.frontiersin.org 12 February 2018 | Volume 9 | Article 130&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#9;Characterization of the in Vitro Metabolic Profile of Evodiaminein Human Liver Microsomes and Hepatocytes by UHPLC-Q Exactive Mass Spectrometer&#10;&#9;Introduction&#10;&#9;Materials and Methods&#10;&#9;Chemicals and Reagents&#10;&#9;Metabolism of Evodiamine in Human Hepatocytes&#10;&#9;Metabolism of Evodiamine in Pooled Human Liver Microsomes&#10;&#9;UHPLC-Q Exactive Mass Spectrometer Conditions&#10;&#10;&#9;Results and Discussion&#10;&#9;Fragmentation of Evodiamine Standard&#10;&#9;LC/MS Analysis of Metabolites of Evodiamine&#10;&#9;Metabolites M1 and M2&#10;&#9;Metabolites M3 and M4&#10;&#9;Metabolite M5&#10;&#9;Metabolite M6&#10;&#9;Metabolite M7&#10;&#9;Metabolite M8&#10;&#9;Metabolite M9&#10;&#9;Metabolite M10&#10;&#9;Metabolite M11&#10;&#9;Metabolite M12&#10;&#9;Metabolite M13&#10;&#9;Metabolites M14 and M15&#10;&#9;Metabolite M16&#10;&#9;Metabolite M17–M19&#10;&#9;In Vitro Metabolism of Evodiamine&#10;&#10;&#9;Conclusion&#10;&#9;Author Contributions&#10;&#9;Funding&#10;&#9;References&#10;&#10;&#10;"/><cas:View sofa="2182" members="1 12 17 22 27 32 37 42 47 52 57 62 67 72 77 82 87 92 97 102 107 112 117 122 127 132 137 142 147 152 157 162 167 172 177 182 187 192 197 202 207 212 217 222 227 232 237 242 247 252 257 262 267 272 277 282 287 292 297 302 307 312 317 322 327 332 337 342 347 352 357 362 367 372 377 382 387 392 397 402 407 412 417 422 427 432 437 442 447 452 457 462 467 472 477 482 487 492 497 502 507 512 517 522 527 532 537 542 547 552 557 562 567 572 577 582 587 592 597 602 607 612 617 622 627 632 637 642 647 652 657 662 667 672 677 682 687 692 697 702 707 712 717 722 727 732 737 742 747 752 757 762 767 772 777 782 787 792 797 802 807 812 817 822 827 832 837 842 847 852 857 862 867 872 877 882 887 892 897 902 907 912 917 922 927 932 937 942 947 952 957 962 967 972 977 982 987 992 997 1002 1007 1012 1017 1022 1027 1032 1037 1042 1047 1052 1057 1062 1067 1072 1077 1082 1087 1092 1097 1102 1107 1112 1117 1122 1127 1132 1137 1142 1147 1152 1157 1162 1167 1172 1177 1182 1187 1192 1197 1202 1207 1212 1217 1222 1227 1232 1237 1242 1247 1252 1257 1262 1267 1272 1277 1282 1287 1292 1297 1302 1307 1312 1317 1322 1327 1332 1337 1342 1347 1352 1357 1362 1367 1372 1377 1382 1387 1392 1397 1402 1407 1412 1417 1422 1427 1432 1437 1442 1447 1452 1457 1462 1467 1472 1477 1482 1487 1492 1497 1502 1507 1512 1517 1522 1527 1532 1537 1542 1547 1552 1557 1562 1567 1572 1577 1582 1587 1592 1597 1602 1607 1612 1617 1622 1627 1632 1637 1642 1647 1652 1657 1662 1667 1672 1677 1682 1687 1692 1697 1702 1707 1712 1717 1722 1727 1732 1737 1742 1747 1752 1757 1762 1767 1772 1777 1782 1787 1792 1797 1802 1807 1812 1817 1822 1827 1832 1837 1842 1847 1852 1857 1862 1867 1872 1877 1882 1887 1892 1897 1902 1907 1912 1917 1922 1927 1932 1937 1942 1947 1952 1957 1962 1967 1972 1977 1982 1987 1992 1997 2002 2007 2012 2017 2022 2027 2032 2037 2042 2047 2052 2057 2062 2067 2072 2077 2082 2087 2092 2097 2102 2107 2112 2117 2122 2127 2132 2137 2142 2147 2152 2157 2162 2167 2172 2177"/></xmi:XMI>